MSD to invest €40m in its Ballydine facility
02 May, 2017
The US drug manufacturer is investing the funds to upgrade technology systems at its Co Tipperary base. New technology being installed under the €40m investment includes a so-called spray drying facility, which is used in the production of a number of new products to increase their solubility and improve how they are absorbed by patients.
For more on this story..